Items where Author is "Szucs, T. D."

Yes

Jeiziner, C. and Suter, K. and Wernli, U. and Barbarino, J. M. and Gong, L. and Whirl-Carrillo, M. and Klein, T. E. and Szucs, T. D. and Hersberger, K. E. and Meyer Zu Schwabedissen, H. E.. (2021) Pharmacogenetic information in Swiss drug labels - a systematic analysis. Pharmacogenomics Journal, 21 (4). pp. 423-434.

Vulsteke, C. and Pfeil, A. M. and Schwenkglenks, M. and Pettengell, R. and Szucs, T. D. and Lambrechts, D. and Peeters, M. and van Dam, P. and Dieudonné, A. S. and Hatse, S. and Neven, P. and Paridaens, R. and Wildiers, H.. (2014) Impact of genetic variability and treatment-related factors on outcome in early breast cancer patients receiving (neo-) adjuvant chemotherapy with 5-fluorouracil, epirubicin and cyclophosphamide, and docetaxel. Breast cancer research and treatment, Vol. 147, H. 3. pp. 557-570.

Moch, H. and Blank, P. R. and Dietel, M. and Elmberger, G. and Kerr, K. M. and Palacios, J. and Penault-Llorca, F. and Rossi, G. and Szucs, T. D.. (2012) Personalized cancer medicine and the future of pathology. Virchows Archiv, Vol. 460. pp. 3-8.

Szucs, T. D. and Blank, P. R. and Schwenkglenks, M. and Aapro, M.. (2011) Potential health economic impact of intravenous iron supplementation to erythropoiesis-stimulating agent treatment in patients with cancer- or chemotherapy-induced anemia. Oncology, 81 (1). pp. 45-49.

Matter-Walstra, K. W. and Dedes, K. J. and Schwenkglenks, M. and Brauchli, P. and Szucs, T. D. and Pestalozzi, B. C.. (2010) Trastuzumab beyond progression: a cost-utility analysis. Annals of Oncology, 21 (11). pp. 2161-2168.

Blank, P. R. and Schwenkglenks, M. and Szucs, T. D.. (2009) Disparities in influenza vaccination coverage rates by target group in five European countries : trends over seven consecutive seasons. Infection, 37. pp. 390-400.